Short answer
NF1 genetic testing looks for an inherited or mosaic NF1 variant when neurofibromatosis type 1 is suspected. It is most useful when the clinical picture is incomplete, the family history is unclear, or a tumor report mentions NF1 and the team needs to know whether the change is germline, mosaic, or tumor-only. A negative blood test does not always end the question if the pattern on the skin, eyes, bones, or tumors still fits NF1.
How testing is framed
| Finding | Testing question | Why it matters |
|---|---|---|
| Classic NF1 features | Does testing add anything beyond the clinical exam? | NF1 is often a clinical diagnosis, but DNA can support family planning or uncertainty. |
| Segmental or subtle findings | Could mosaic NF1 explain the pattern? | Mosaic disease can be missed in blood and can change recurrence counseling. |
| Tumor-only NF1 result | Is the variant germline or somatic? | Tumor-only findings do not automatically equal inherited NF1. |
| Negative blood result with strong features | Was the right tissue tested? | Blood can miss low-level mosaicism or tissue-limited disease. |
What the result can change
A confirmed NF1 diagnosis can change ophthalmology, skin, blood pressure, learning, skeletal, neurologic, and tumor surveillance. A positive germline result can also affect family counseling and targeted testing. A VUS should not be treated like a confirmed diagnosis, and a negative blood test may not fully exclude mosaic disease when clinical features are strong.
When blood can miss the answer
Mosaic NF1 can be present in only some tissues, so blood may not show the variant clearly. That is why segmental findings, tumor tissue, skin lesions, or paired tumor-normal analysis sometimes matter more than a single blood result. If the pattern still looks like NF1, the next question may be whether another tissue or a genetics specialist should review the case.
Questions to ask
- Does the person meet clinical diagnostic criteria even before genetic testing?
- Did the test include sequencing and deletion/duplication analysis?
- Was the variant found in blood, saliva, tumor tissue, or another sample type?
- Could mosaic NF1 explain a negative blood test?
- What surveillance is recommended for optic glioma, plexiform neurofibroma, blood pressure, learning, and other NF1 concerns?
What the result still cannot prove
An NF1 result can clarify tumor predisposition, but it does not by itself capture the full severity of the condition, the timing of complications, or the need for symptom-based follow-up.
FAQ
What does an NF1 test confirm?
It can confirm an inherited or mosaic NF1 variant, but the clinical picture still matters because many people with NF1 are diagnosed from exam findings and family history.
Why can blood testing be negative?
The variant may be mosaic or tissue-limited, so blood can miss it even when the skin, tumors, or other features still point toward NF1.
Does an NF1 tumor result mean inherited disease?
Not automatically. A tumor-only NF1 finding can be somatic, so the lab report and sample type need to be checked before family-risk conclusions are made.
Does a positive result change surveillance?
Yes. A confirmed NF1 result can affect eye exams, blood pressure checks, neurologic follow-up, and tumor surveillance planning.
Should family members be tested?
Family testing is most helpful when the familial variant is known or when the result is clearly germline. Mosaic or uncertain results need a genetics review first.
Who should review the result?
A genetics professional is often helpful because mosaicism, tumor-only findings, and family implications can be easy to misread without context.
Related guides: RASopathy genetic testing, RET MEN2 genetic testing, genetic counselor guide, and tumor genomic versus inherited testing.